MDGC yields 2000000.00% · JNJ yields 2.13%● Live data
📍 MDGC pulled ahead of the other in Year 1
Combined, MDGC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDGC + JNJ for your $10,000?
MediaG3, Inc. engages in the design, development, and deployment of wireless broadband Internet, wireless networks, fixed and mobile Internet, communications, and media and entertainment products and services for individuals and companies of various sizes. It provides Wi-Fi and wireless networks and ultra high speed wireless broadband Internet products and solutions. The company offers point-to-point and point-to-multipoint digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. Its products include broadband wireless access base stations and customer premises equipment for fixed and mobile point-to-point digital microwave radio systems for Internet access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. The company also provides Internet and Internet-related products and services, as well as engages in residential ISP services, broadband wholesale marketing, and retail direct fiber connections to the Internet for large and small businesses. Further, its online store offers Internet related products and services. MediaG3, Inc. was incorporated in 2005 and is headquartered in San Jose, California.
Full MDGC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.